Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.83% | 204.57 | 1.3% | $443.37m | |
| BIIB | Biogen Inc. | 0.31% | 226.47 | 1.3% | $383.48m | |
| GILD | Gilead Sciences, Inc. | 1.61% | 65.55 | 0.9% | $368.10m | |
| CELG | Celgene Corporation | 0.74% | 101.14 | 1.3% | $355.01m | |
| ILMN | Illumina, Inc. | 0.35% | 311.41 | 3.5% | $267.64m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.05% | 305.29 | 2.6% | $219.64m | |
| EXAS | Exact Sciences Corporation | 4.88% | 99.48 | 24.1% | $209.12m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 3.29% | 104.68 | 2.0% | $187.03m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.69% | 176.53 | 1.9% | $181.86m | |
| A | Agilent Technologies, Inc. | 1.01% | 75.94 | 1.6% | $155.32m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.46% | 86.95 | 14.6% | $143.78m | |
| ALDR | Alder Biopharmaceuticals, Inc. | -0.11% | 18.90 | 10.2% | $132.19m | |
| BMRN | BioMarin Pharmaceutical Inc. | 2.14% | 68.68 | 4.3% | $98.00m | |
| ACAD | ACADIA Pharmaceuticals Inc. | 1.82% | 40.20 | 13.4% | $91.21m | |
| NKTR | Nektar Therapeutics | 9.55% | 17.39 | 5.5% | $86.25m |
Company Profile
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA.